The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $42.49

Today's change+1.36 +3.31%
Updated December 18 2:29 PM EST. Delayed by at least 15 minutes.
 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $42.49

Today's change+1.36 +3.31%
Updated December 18 2:29 PM EST. Delayed by at least 15 minutes.

Zoetis Inc up sharply

Zoetis Inc is up sharply today, rallying (U.S.)$1.36 or 3.31% to (U.S.)$42.49. Shares have lost 0.91% over the last five days, but have gained 29.98% over the last year to date. This security has outperformed the S&P 500 by 19.14% during the last year.

Key company metrics

  • Open(U.S.) $41.84
  • Previous close(U.S.) $41.13
  • High(U.S.) $42.72
  • Low(U.S.) $41.79
  • Bid / Ask(U.S.) $42.48 / (U.S.) $42.49
  • YTD % change+29.98%
  • Volume4,646,074
  • Average volume (10-day)5,143,588
  • Average volume (1-month)4,713,191
  • Average volume (3-month)5,085,612
  • 52-week range(U.S.) $28.14 to (U.S.) $45.24
  • Beta--
  • Trailing P/E37.91×
  • P/E 1 year forward26.79×
  • Forward PEG2.16×
  • Indicated annual dividend(U.S.) $0.29
  • Dividend yield0.68%
  • Trailing EPS(U.S.) $1.12
Updated December 18 2:29 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.97%

Based on its net profit margin of 11.97%, Zoetis Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.46%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014Dec 31, 201312/31/2013
Revenue1,2101,1581,0971,254
Total other revenue--------
Total revenue1,2101,1581,0971,254
Gross profit776745718768
Total cost of revenue434413379486
Total operating expense9729588701,128
Selling / general / administrative394396356438
Research & development939287121
Depreciation / amortization16151515
Interest expense (income), net operating29292930
Unusual expense (income)712136
Other operating expenses, total-8-6-6-6
Operating income238200227126
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax238200227126
Income after tax167139155104
Income tax, total71617222
Net income166136155105
Total adjustments to net income--------
Net income before extra. items166136155105
Minority interest-1-301
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items166136155105
Inc. avail. to common incl. extra. items166136155105
Diluted net income166136155105
Dilution adjustment----0--
Diluted weighted average shares502502501501
Diluted EPS excluding extraordinary itemsvalue per share0.330.270.310.21
Dividends per sharevalue per share0.070.000.070.07
Diluted normalized EPSvalue per share0.340.290.310.27